TAPIMMUNE INC (TPIV)

Company Overview
TapImmune Inc. engages in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. The company focuses on conducting studies using its transporters of antigen processing (TAP) gene technology in combination with an adeno virus. Its products include TAP cancer vaccine, which is under preclinical trial used for the treatment of breast cancer, prostate cancer, lung cancer, liver cancer, melanoma, renal cancer, and colorectal cancer. The company was founded in 1999 and is based in Seattle, Washington.
read more

Watch the video to learn about the probability of TAPIMMUNE INC (TPIV) Chart Signal as of Feb 08, 2016

Hotstocked Precision will calculate the probabilities of TAPIMMUNE INC (TPIV)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads: 800,000+
FREE DOWNLOAD

QUOTE

As of 03:09AM EST February 08, 2016
$ N/A   (%)
Today's Open: N/A Previous Close: N/A
Today's High: N/A Volume: N/A
Today's Low: N/A Avg Vol: 461,883
52 Week High: 1.71 Bid (size): N/A
52 Week Low: 0.121 Ask (size): N/A

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 1551 Eastlake Avenue East, Suite 100, Seattle, WA 98102, United States
Mailing Address: -
Phone: 206-504-7279
Fax: -
Website: http//www.tapimmune.com

Company Details:

Symbol: TPIV
SIC: -
State location: A1
Sector: -
State of Inc: NV
Employees: 2
Type: -

Key executives:

Name Age Position

Watch the video to learn about the probability of TAPIMMUNE INC (TPIV) Chart Signal as of Feb 08, 2016

This free program will calculate the probabilities of TAPIMMUNE INC (TPIV) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads: 800,000+
FREE DOWNLOAD

LATEST ARTICLES

TapImmune Inc. (OTCMKTS:TPIV) Regains Some Ground January 25, 2016

After almost reaching $1 per share on high volumes in the first half of December we saw the stock of TapImmune Inc. (OTCMKTS:TPIV) lose the altitude as quickly as it had gained it and continue to move sideways into the beginning of 2016. read more

TapImmune Inc. (OTCMKTS:TPIV) Is Still Unstable January 15, 2016

TapImmune Inc. (OTCMKTS:TPIV) started today's session with an ugly 10% gap down, but now it looks like it could recover from that nasty red opening. read more

TapImmune Inc. (OTCMKTS:TPIV) Crushed By Lack Of News January 14, 2016

After a decent climb in the beginning of December, following an announcement of some progress with several of the company’s substances, we saw the stock of TapImmune Inc. (OTCMKTS:TPIV) correct and lose the altitude it gained very fast. read more

TapImmune Inc. (OTCMKS:TPIV) Starts Falling Once More January 8, 2016

After briefly stabilizing around the 60 cents per share mark the stock of TapImmune Inc. (OTCMKTS:TPIV) is now once again sliding down the chart. On Wednesday the ticker corrected by 3.5% while yesterday it accelerated its decline and registered a loss ... read more

LATEST STOCK PROMOTIONS

Weekend Stock Alerts Jan 31, 2016, 15:13

  Click to view this email in a browser January 31, 2016 Weekend Stock Alerts We hope you are all having a great weekend!   We are trying something a little new this weekend.  Because of our success with Pudo, Incorporated we have been getting a lot of interest in our marketing programs.   This week we will be rolling out 4 new companies, all in different capacities.  However, we wanted to take read more

Promoter: Innovative Marketing Paying Party: No Third Party Max Profit: 6.65% Gain at close: Pending
Stock: TPIV Compensation: $5,000 Avg $ Volume for Period: UNKNOWN

TPIV vaccine to be studied in 13.3M grant to Mayo Clinic Sep 22, 2015, 19:03

TPIV vaccine to be studied in U.S. Department of Defense grant to Mayo Clinic   TapImmune Inc. (TPIV) TapImmune Inc. (TPIV) is an immunotherapy company specializing in the development of innovative technologies for the treatment of cancer, including metastasis, and infectious disease. The Company's peptide or nucleic acid-based immunotherapeutics comprise one or multiple read more

Promoter: Buzz Stocks Paying Party: UNKNOWN Max Profit: 3.99% Gain at close: Pending
Stock: TPIV Compensation: No compensation Avg $ Volume for Period: UNKNOWN

PennyStockProphet - TPIV - New Alert: .65 Biotech Gaining... Sep 22, 2015, 18:46

PSP Free Members, I’ve got an incredible “breakout” alert in the Biotech Industry that could provide the next windfall you have been looking for. And it happens to be one of the hottest charts I’ve seen lately.   Best of all that strength looks to be building as this Biotech held steady in Tuesdays’ session even when the overall market was pulling back. One of the greatest read more

Promoter: Penny Stock Prophet Paying Party: UNKNOWN Max Profit: 3.99% Gain at close: Pending
Stock: TPIV Compensation: No compensation Avg $ Volume for Period: UNKNOWN

TapImmune, Inc. (TPIV) MESSAGE BOARD

Post # Subject Re Name Date
1 was this today?? 0
2 MBHC is IN the HOT "Mobile app" sector.Its... 0
3 Telco Cuba(SUGO) is a good "U.S.-Cuba"... 0
4 Telco Cuba(SUGO) is a good "U.S.-Cuba"... 0
5 TapImmune (TPIV)- STOCK TRADING HALTED... 1
6 Stop loss at? 0
7 TPIV - chart looking nice...IMO! The... 1